Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification

被引:42
作者
Carbone, Daniela [1 ]
Vestuto, Vincenzo [2 ]
Ferraro, Maria Rosalia [1 ]
Ciaglia, Tania [2 ]
Pecoraro, Camilla [1 ]
Sommella, Eduardo [2 ]
Cascioferro, Stella [1 ]
Salviati, Emanuela [2 ]
Novi, Sara [2 ]
Tecce, Mario Felice [2 ]
Amodio, Giuseppina [3 ]
Iraci, Nunzio [4 ]
Cirrincione, Girolamo [1 ]
Campiglia, Pietro [2 ]
Diana, Patrizia [1 ]
Bertamino, Alessia [2 ]
Parrino, Barbara [1 ]
Ostacolo, Carmine [5 ]
机构
[1] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Via Archirafi 32, I-90123 Palermo, Italy
[2] Univ Salerno, Dept Pharm, Via G Paolo 2, I-84084 Fisciano, SA, Italy
[3] Dept Med Surg & Dent Scuola Med Salernitana DIPME, Via S Allende, I-84081 Baronissi, SA, Italy
[4] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno dAlcontres 31, I-98166 Messina, Italy
[5] Univ Naples Federico II, Dept Pharm, Via D Montesano 49, I-80131 Naples, Italy
关键词
Nortopsentin analogues; Marine alkaloids; GLS-1; inhibitors; Anticancer agents; Metabolomics; GLUTAMINE-METABOLISM; CANCER; PROTEIN; ACID;
D O I
10.1016/j.ejmech.2022.114233
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The enzyme glutaminase-1 (GLS-1) has shown a clear and coherent implication in the progression and exacerbation of different aggressive tumors such as glioblastoma, hepatocarcinoma, pancreas, bone, and triple-negative breast cancer. Few chemotypes are currently available as selective GLS-1 inhibitors, and still, fewer of them are at the clinical stage. In the present paper, starting from a naturally-inspired antitumor compound library, metabolomics has been used to putatively identify the molecular mechanism underlying biological activity. GLS-1 was identified as a potential target. Biochemical analysis confirmed the hypothesis leading to the identification of a new hit compound acting as a GLS-1 selective inhibitor (IC50 = 3.96 +/- 1.05 mM), compared to the GLS-2 isoform (IC50 = 12.90 +/- 0.87 mM), with remarkable antitumor potency over different aggressive tumor cell lines. Molecular modelling studies revealed new insight into the drug-target interaction providing robust SAR clues for the rational hit-tolead development. The approach undertaken underlines the wide potential of metabolomics applied to drug discovery, particularly in target identification and hit discovery following phenotype screening. (c) 2022 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:26
相关论文
共 63 条
[1]   Protein interaction evolution from promiscuity to specificity with reduced flexibility in an increasingly complex network [J].
Alhindi, T. ;
Zhang, Z. ;
Ruelens, P. ;
Coenen, H. ;
Degroote, H. ;
Iraci, N. ;
Geuten, K. .
SCIENTIFIC REPORTS, 2017, 7
[2]  
[Anonymous], 2021, SCHRODINGER RELEASE
[3]   Natural products in drug discovery: advances and opportunities [J].
Atanasov, Atanas G. ;
Zotchev, Sergey B. ;
Dirsch, Verena M. ;
Supuran, Claudiu T. .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (03) :200-216
[4]   UniProt: the universal protein knowledgebase in 2021 [J].
Bateman, Alex ;
Martin, Maria-Jesus ;
Orchard, Sandra ;
Magrane, Michele ;
Agivetova, Rahat ;
Ahmad, Shadab ;
Alpi, Emanuele ;
Bowler-Barnett, Emily H. ;
Britto, Ramona ;
Bursteinas, Borisas ;
Bye-A-Jee, Hema ;
Coetzee, Ray ;
Cukura, Austra ;
Da Silva, Alan ;
Denny, Paul ;
Dogan, Tunca ;
Ebenezer, ThankGod ;
Fan, Jun ;
Castro, Leyla Garcia ;
Garmiri, Penelope ;
Georghiou, George ;
Gonzales, Leonardo ;
Hatton-Ellis, Emma ;
Hussein, Abdulrahman ;
Ignatchenko, Alexandr ;
Insana, Giuseppe ;
Ishtiaq, Rizwan ;
Jokinen, Petteri ;
Joshi, Vishal ;
Jyothi, Dushyanth ;
Lock, Antonia ;
Lopez, Rodrigo ;
Luciani, Aurelien ;
Luo, Jie ;
Lussi, Yvonne ;
Mac-Dougall, Alistair ;
Madeira, Fabio ;
Mahmoudy, Mahdi ;
Menchi, Manuela ;
Mishra, Alok ;
Moulang, Katie ;
Nightingale, Andrew ;
Oliveira, Carla Susana ;
Pundir, Sangya ;
Qi, Guoying ;
Raj, Shriya ;
Rice, Daniel ;
Lopez, Milagros Rodriguez ;
Saidi, Rabie ;
Sampson, Joseph .
NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) :D480-D489
[5]   Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity [J].
Bertamino, Alessia ;
Iraci, Nunzio ;
Ostacolo, Carmine ;
Arnbrosino, Paolo ;
Musella, Simona ;
Di Sarno, Veronica ;
Ciaglia, Tania ;
Pepe, Giacomo ;
Sala, Marina ;
Soldovier, Maria Virginia ;
Mosca, Ilaria ;
Gonzalez-Rodriguez, Sara ;
Fernandez-Carvajal, Asia ;
Ferrer-Montiel, Antonio ;
Novellino, Ettore ;
Taglialatela, Maurizio ;
Campiglia, Pietro ;
Gomez-Monterrey, Isabel .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) :6140-6152
[6]  
Bowers K.J., 2006, SC 06 P 2006 ACM IEE, P43
[7]  
bpsbioscience, NTR
[8]   Thiazole Analogues of the Marine Alkaloid Nortopsentin as Inhibitors of Bacterial Biofilm Formation [J].
Carbone, Anna ;
Cascioferro, Stella ;
Parrino, Barbara ;
Carbone, Daniela ;
Pecoraro, Camilla ;
Schillaci, Domenico ;
Cusimano, Maria Grazia ;
Cirrincione, Girolamo ;
Diana, Patrizia .
MOLECULES, 2021, 26 (01)
[9]   1,2,4-Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase [J].
Carbone, Daniela ;
Parrino, Barbara ;
Cascioferro, Stella ;
Pecoraro, Camilla ;
Giovannetti, Elisa ;
Di Sarno, Veronica ;
Musella, Simona ;
Auriemma, Giulia ;
Cirrincione, Girolamo ;
Diana, Patrizia .
CHEMMEDCHEM, 2021, 16 (03) :537-554
[10]   New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity [J].
Cascioferro, Stella ;
Attanzio, Alessandro ;
Di Sarno, Veronica ;
Musella, Simona ;
Tesoriere, Luisa ;
Cirrincione, Girolamo ;
Diana, Patrizia ;
Parrino, Barbara .
MARINE DRUGS, 2019, 17 (01)